<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131015">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01768377</url>
  </required_header>
  <id_info>
    <org_study_id>130-1928</org_study_id>
    <nct_id>NCT01768377</nct_id>
  </id_info>
  <brief_title>Comparison of Intubation With Nerve Block and With Sedation in Awake Patients</brief_title>
  <official_title>Comparison of in Intubation With Nerve Block and Intubation With Sedation in Awake Patients in Terms of Efficacy, Complications and Physician's Satisfaction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tehran University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tehran University of Medical Sciences</source>
  <oversight_info>
    <authority>Iran: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare intubation with nerve block with intubation with
      sedation in awake patients in terms of efficacy, ease, and the rate of complications and
      physician satisfaction
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">February 2013</completion_date>
  <primary_completion_date type="Anticipated">February 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Time required for intubation in seconds</measure>
    <time_frame>From start of the intubation attempt for an average of one minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>The interval is measured from the time that the healthcare provider attempts intubation until a successful intubation is achieved.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>physicians' perception of the difficulty of the procedure</measure>
    <time_frame>Within an average of 30 minutes after completion of the procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>Physicians' perception about the difficulty of the procedure is assessed using a 5-point Likert type scale (ranging from very easy to very difficult)verbally administered to the healthcare provider immediately (within 30 minutes) after completion of the intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Adverse Events</measure>
    <time_frame>From the start of the procedure until 30 minutes after the procedure is completed</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of patients developing any of the following complications (cough, esophageal intubation) from the start of the procedure until 30 minutes after completion of the procedure. This will represent the rate of complications</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Intubation Complication</condition>
  <arm_group>
    <arm_group_label>Intubation with sedation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sedation with midazolam and analgesia with fentanyl</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intubation with Nerve block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laryngeal plus supraglottic plus intratracheal nerve block plus sedation with midazolam</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nerve block with Lidocain</intervention_name>
    <description>Lidocain 2% topical injection, 0.5 - 1 cc Lidocain 4% topical injection, 3 cc Lidocain 10% topical spray , total dose 50 mg</description>
    <arm_group_label>Intubation with Nerve block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Fentanyl 2 microgram/Kg BW IV</description>
    <arm_group_label>Intubation with sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Midazolam 0.05 mg/kg BW IV infusion</description>
    <arm_group_label>Intubation with sedation</arm_group_label>
    <arm_group_label>Intubation with Nerve block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Candidate for intubation with methods other than RSI

          -  Age&gt;= 18 years

          -  Patient or patient's guardian's consent

        Exclusion Criteria:

          -  Need for RSI or crash intubation

          -  Allergy to Lidocain in block group

          -  Allergy to opioid drugs in sedation group

          -  Allergy to midazolam in either group
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammad Jalili, MD</last_name>
    <role>Study Director</role>
    <affiliation>TUMS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amir Nejati, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>TUMS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohammad Jalili, MD</last_name>
    <phone>+98(912)5483998</phone>
    <email>mjalii@tums.ac.ir</email>
  </overall_contact>
  <location>
    <facility>
      <name>Imam Khomeini Hospital</name>
      <address>
        <city>Tehran</city>
        <zip>1417613151</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammad Jalili, MD</last_name>
      <phone>+98(21)66404377</phone>
      <email>mjalili@tums.ac.ir</email>
    </contact>
    <investigator>
      <last_name>Mohammad Jalili, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amir Nejati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arsalan Azizpour, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 14, 2013</lastchanged_date>
  <firstreceived_date>January 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Awake intubation</keyword>
  <keyword>Nerve block</keyword>
  <keyword>Sedation</keyword>
  <keyword>Physician satisfaction</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
